Orphan drugs and where to launch them: The keys to Europe’s forgotten territories
Pharmaceutical Technology
JULY 14, 2022
The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Centralised incentives are also in place across Europe, as well as at the national level in some EU states. Go-to-market strategies. Efforts have been made to change this.
Let's personalize your content